Impairment of synaptic vesicle exocytosis and recycling during neuromuscular weakness produced in mice by 2,4-dithiobiuret

Journal of Neurophysiology

Volumn 88, Issue 6, 2002, Pages 3243-3258

  Xu, You Fen ^a   Autio, Dawn ^a   Rheuben, Mary B ^b   Atchison, William D ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA LATROTOXIN; DITHIOBIURET; HORSERADISH PEROXIDASE; POTASSIUM ION;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BOTULISM; CONTROLLED STUDY; EATON LAMBERT SYNDROME; ENDOCYTOSIS; ENDPLATE POTENTIAL; EXOCYTOSIS; MALE; MOUSE; MUSCLE WEAKNESS; NERVE ENDING; NERVE STIMULATION; NEUROAXONAL DYSTROPHY; NEUROMUSCULAR DISEASE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; SYNAPSE VESICLE;

EID: 0036898551     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00934.2001     Document Type: Article

References (60)

1. Atchison WD. Alteration of spontaneous and evoked release of acetylcholine during dithiobiuret-induced neuromuscular weakness. J Pharmacol Exp Ther 249: 735-743, 1989.
2. Atchison WD. Reduced safety factor for neuromuscular transmission and abnormal quantal secretion precede neuromuscular weakness induced by dithiobiuret. Toxicol Appl Pharmacol 106: 234-244, 1990.
3. Atchison WD, Lalley PM, Cassens RG, and Peterson RE. Depression of neuromuscular function in the rat by chronic 2,4-dithiobiuret treatment. Neurotoxicology 2: 329-346, 1981a.
4. Atchison WD, Mellon WS, Lalley PM, and Peterson RE. Dithiobiuret-induced muscle weakness in rats: Evidence for a prejunctional effect. Neurotoxicology 3: 44-54, 1982.
5. Atchison WD and Peterson RE. Potential neuromuscular toxicity of 2,4-dithiobiuret in the rat. Toxicol Appl Pharmacol 57: 63-68, 1981.
6. Atchison WD, Yang KH, and Peterson RE. Dithiobiuret toxicity in the rat: Evidence for latency and cumulative dose thresholds. Toxicol Appl Pharmacol 61: 166-171, 1981b.
7. Betz WJ and Bewick GS. Optical analysis of synaptic vesicle recycling at the frog neuromuscular junction. Science 255: 200-203, 1992.
8. Betz WJ and Bewick GS. Optical and electrophysiological monitoring of transmitter release and synaptic vesicle recycling at the frog neuromuscular junction. J Physiol (Lond) 460: 287-309, 1993.
9. Betz WJ, Bewick GS, and Ridge RM. Intracellular movements of fluorescently-labeled synaptic vesicles in frog motor nerve terminals during nerve stimulation. Neuron 9: 805-813, 1992a.
10. Betz WJ and Henkel AW. Okadaic acid disrupts clusters of synaptic vesicles in frog motor nerve terminals. J Cell Biol 124: 843-854, 1994.
11. Betz WJ, Mao F, and Bewick GS. Activity-dependent fluorescent staining and destaining in living vertebrate motor nerve terminals. J Neurosci 12: 363-375, 1992b.
12. Broadie K, Prokop A, Bellen HJ, O'Kane CJ, Schulze KL, and Sweeney ST. Syntaxin and synaptobrevin function downstream of vesicle docking in Drosophila. Neuron 15: 663-673, 1995.
13. Collier B and MacIntosh FC. The source of choline for acetylcholine synthesis in a sympathetic ganglion. Can J Physiol Pharmacol 47: 127-135, 1969.
14. Cousin MA and Nicholls DC. Synaptic vesicle recycling in cultured cerebellar granule cells: Role of vesicular acidification and refilling. J Neurochem 69: 1928-1935, 1997.
15. Cull-Candy SG, Lundh H, and Thesleff S. Effects of botulinum toxin on neuromuscular transmission in the rat. J Physiol (Lond) 260: 177-203, 1976.
16. De Leon GA and Mitchell MH. Histological and ultrastructural features of dystrophic isocortical axons in infantile dystrophy (Seitelberger's disease) Acta Neuropathol (Berl) 66: 89-97, 1985.
17. Dreyer F, Rosenberg F, Becker C, Bigalke H, and Penner R. Differential effects of various secretagogues on quantal transmitter release from mouse motor nerve terminals treated with botulinum A and tetanus toxin. Naunyn-Schmiedeberg's Arch Pharmacol 335: 1-7, 1987.
18. Engel AG and Ohno K. Congenital myasthenic syndromes. Adv Neurol 88: 203-215, 2002a.
19. Engel AG and Ohno K. Congenital myasthenic syndromes: Genetic defects of the neuromuscular junction. Curr Neurol Neurosci Rep 2: 78-88, 2002b.
20. Henkel AW and Betz WJ. Monitoring of black widow spider venom (BWSV) induced exo- and endocytosis in living frog motor nerve terminals with FM1-43. Neuropharmacology 34: 1397-1406, 1995.
21. Henkel AW, Simpson LL, Ridge RM, and Betz WJ. Synaptic vesicle movements monitored by fluorescence recovery after photobleaching in nerve terminals stained with FM1-43. J Neurosci 16: 3960-3967, 1996.
22. Heuser JE and Reese TS. Evidence for recycling of synaptic vesicle membrane during transmitter release at the frog neuromuscular junction. J Cell Biol 57: 315-344, 1973.
23. Heuser JE and Reese TS. Structural changes after transmitter release at the frog neuromuscular junction. J Cell Biol 88: 564-580, 1981.
24. Humeau Y, Doussau F, Grant NJ, and Poulain B. How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie 82: 427-446, 2000.
25. Ireland LM, Yan C, Nelson LM, and Atchison WD. Differential effects of 2,4-dithiobiuret on the synthesis and release of acetylcholine and dopamine from rat pheochromocytoma (PC12) cells. J Pharmacol Exp Ther 275: 1453-1462, 1995.
26. Itoh K, Konishi A, Nomura S, Mizuno N, Nakamura Y, and Sugimoto T. Application of coupled oxidation reaction to electron microscopic demonstration of horseradish peroxidase: Cobalt-glucose oxidase method. Brain Res 175: 341-346, 1979.
27. Jones HB. Dithiobiuret neurotoxicity: an ultrastructural investigation of the lesion in preterminal axons and motor endplates in the rat lumbricale muscle. Acta Neuropathol (Berl) 78: 72-85, 1989.
28. Kao I, Drachman DB, and Price DI. Botulinum toxin: Mechanism of presynaptic blockade. Science 193: 1256-1258, 1976.
29. Kemplay S. Effects of dithiobiuret intoxication on motor end plates in sternocostalis and hindlimb muscles of female rats. Acta Neuropathol (Berl) 65: 77-84, 1984.
30. Kimura S, Sasaki Y, Warlo I, and Goebel HH. Axonal pathology of the skin in infantile neuroaxonal dystrophy. Acta Neuropathol (Berl) 75: 212-215, 1987.
31. King MJ, Atwood HL, and Govind CK. Structural features of crayfish phasic and tonic neuromuscular terminals. J Comp Neurol 372: 618-626, 1996.
32. Kuromi H and Kidokoro Y. Two distinct pools of synaptic vesicles in single presynaptic boutons in a temperature-sensitive Drosophila mutant shibire. Neuron 20: 917-925, 1998.
33. Kuromi H and Kidokoro Y. The optically determined size of exo/endo cycling vesicle pool correlates with the quantal content at the neuromuscular junction of Drosophila larvae. J Neurosci 19: 1557-1565, 1999.
34. Lundh H, Leander S, and Thesleff S. Antagonism of the paralysis produced by botulinum toxin in the rat. The effects of tetraethylammonium, guanidine and 4-aminopyridine. J Neurol Sci 32: 29-43, 1977.
35. McArdle JJ, Angout-Petit D, Mallart A, Bournard R, Faille L, and Brigant JL. Advantages of the triangularis sterni muscle of the mouse for investigations of synaptic phenomena. Neurosci Methods 4: 109-115, 1981.
36. Parsons RL, Calupca MA, Merriam LA, and Prior C. Empty synaptic vesicles recycle and undergo exocytosis at vesamicol-treated motor nerve terminals. J Neurophysiol 81: 2696-2700, 1999.
37. Parsons SM, Prior C, and Marshall IG. Acetylcholine transport, storage, and release. Int Rev Neurobiol 35: 279-390, 1993.
38. Pyle JL, Kavalali ET, Piedras-Rienteria ES, and Tsien RW. Rapid reuse of readily releasable pool vesicles at hippocampal synapses. Neuron 28: 221-231, 2000.
39. Rheuben MB, Autio DM, and Atchison WD. Endocytic recycling of vesicular structures in 2,4-dithiobiuret (DTB) treated motor nerve terminals. Soc Neurosci Abstr 24: 78, 1998.
40. Ribchester RR, Mao F, and Betz WJ. Optical measurements of activity-dependent membrane recycling in motor nerve terminals of mammalian skeletal muscle. Proc R Soc Lond B Biol Sci 255: 61-66, 1994.
41. Richards DA and Betz WJ. Monitoring vesicle traffic at the frog neuromuscular junction with the styryl dye FM 1-43. Soc Neurosci Abstr 24: 77, 1998.
42. Richards DA, Guatimosim C, and Betz WJ. Two endocytic recycling routes selectively fill two vesicle pools in frog motor nerve terminals. Neuron 27: 551-559, 2000.
43. Ryan TA, Li L, Chin LS, Greengard P, and Smith SJ. Synaptic vesicle recycling in synapsin I knock-out mice. J Cell Biol 134: 1219-1227, 1996a.
44. Ryan TA, Reuter H, Wendland B, Schweizer FE, and Tsien RW. The kinetics of synaptic vesicle recycling measured at single presynaptic boutons. Neuron 11: 713-724, 1993.
45. Ryan TA, Smith SJ, and Reuter H. The timing of synaptic vesicle endocytosis. Proc Natl Acad Sci USA 93: 5567-5571, 1996b.
46. Sahenk Z. Distal terminal axonopathy produced by 2,4-dithiobiuret: effects of long-term intoxication in rats. Acta Neuropathol (Berl) 81: 141-147, 1990.
47. Sellin LC. The action of botulinum toxin at the neuromuscular junction. Med Biol 59: 11-20, 1981.
48. Sellin LC. Botulism - An update. Mil Med 149: 12-16, 1984.
49. Spitsbergen JM and Atchison WD. Acute alterations in murine neuromuscular transmission following exposure to a nonparalytic dose of dithiobiuret. Toxicol Appl Pharmacol 102: 68-79, 1990.
50. Spitsbergen JM and Atchison WD. Voltage clamp analysis reveals multiple populations of quanta released at neuromuscular junctions of rats treated with 2,4-dithiobiuret. J Pharmacol Exp Ther 256: 159-163, 1991.
51. Steel RGD and Torrie JH. Principles and Procedures of Statistics. New York: McGraw Hill, 1960.
52. Südhof TC. The synaptic vesicle cycle revisited. Neuron 28: 317-320, 2000.
53. Südhof TC. α-latrotoxin and its receptors: Neurexins and CIRL/Latrophilins. Annu Rev Neurosci 24: 933-962, 2001.
54. Sun JY and Wu LG. Fast kinetics of exocytosis revealed by simultaneous measurements of presynaptic capacitance and postsynaptic currents at a central synapse. Neuron 30: 171-182, 2001.
55. Teng H and Wilkinson RS. Clathrin-mediated endocytosis near active zones in snake motor boutons. J Neurosci 20: 7986-7993, 2000.
56. Weiler MH, Williams KD, and Peterson RE. Effects of 2,4-dithiobiuret treatment in rats on cholinergic function and metabolism of the extensor digitorum longus muscle. Toxicol Appl Pharmacol 84: 220-231, 1986.
57. Wu LG and Betz WJ. Nerve activity but not intracellular calcium determines the time course of endocytosis at the frog neuromuscular junction. Neuron 17: 769-779, 1996.
58. + currents of mouse motor nerve terminals. J Pharmacol Exp Ther 279: 1229-1236, 1996a.
59. Xu Y-F and Atchison WD. Inhibition by 2,4-dithiobiuret of stimulus-induced enhancement of ACh release at rat neuromuscular junctions. Soc Neurosci Abstr 22: 1740, 1996b.
60. Xu Y-F and Atchison WD. Inhibition by 2,4-dithiobiuret of vesicle exocytosis and endocytosis at mouse neuromuscular junctions. Soc Neurosci Abstr 24: 78, 1998.